GOLDFINCH BIOPHARMA
Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease. It is integrating breakthroughs in kidney genetics and biology to identify new therapeutic targets and advance first-in-class drug candidates to treat patients with kidney disease. Its Product Engine will industrialize the integration of genetics and kidney biology and confer a differentiated ability to identify, validate, and pursue novel therapeutic targets to treat progressive kidney disease. The company was founded in 2016 and is based in Cambridge, Massachusetts.
GOLDFINCH BIOPHARMA
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2015-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.goldfinchbio.com
Total Employee:
11+
Status:
Active
Contact:
(617)337-4200
Email Addresses:
[email protected]
Total Funding:
210 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Domain Not Resolving Wordpress Plugins
Similar Organizations
Anchiano Therapeutics
Anchiano is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Noctrix Health
Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.
Current Advisors List
Current Employees Featured
Founder
Investors List
BlackRock
BlackRock investment in Series B - Goldfinch Biopharma
Gilead Sciences
Gilead Sciences investment in Series B - Goldfinch Biopharma
Schroder Adveq
Schroder Adveq investment in Series B - Goldfinch Biopharma
Ally Bridge Group
Ally Bridge Group investment in Series B - Goldfinch Biopharma
Irving Investors
Irving Investors investment in Series B - Goldfinch Biopharma
Eventide
Eventide investment in Series B - Goldfinch Biopharma
Regent Capital
Regent Capital investment in Series B - Goldfinch Biopharma
Casdin Capital
Casdin Capital investment in Series B - Goldfinch Biopharma
Wellington Management
Wellington Management investment in Series B - Goldfinch Biopharma
Gilead Sciences
Gilead Sciences investment in Corporate Round - Goldfinch Biopharma
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-24 | Goldfinch Bio Announces Appointment of Edwin J. Tucker, M.D., as Chief Medical Officer |
Official Site Inspections
http://www.goldfinchbio.com
- Host name: 71.29.184.35.bc.googleusercontent.com
- IP address: 35.184.29.71
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
